Anterior cruciate ligament rupture (S83.53, M23.61) or Anterior cruciate ligament rupture (S83.53, M23.61) with injury of the meniscus (M23.3, S83.2) S83.53 M23.61 M23.3 S83.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Possession of an app-enabled smartphone with Internet access that meets the app's compatibility requirements - Own e-mail address for registration - Willingness to use the app regularly and to participate in other study-related measures (visits, surveys, etc.) - For the OV cohort: = 2 weeks and = 6 weeks between study inclusion and surgery
Exclusion criteria
Exclusion criteria: - Insufficient knowledge of German - Expected insufficient compliance (e.g. due to severe mental illness) - Pregnancy - Previous or ongoing treatment with Novio Knee or a comparable digital application in the investigated indication area - Dizziness or impaired perception, e.g. due to taking specific (long-term) medication - Lack of clearance to exercise the knee - Fever, flu-like infection - Uncontrolled or uncontrolled acute and chronic inflammatory diseases - Infections or signs of infection in the knee joint after an operation - Cardiac, pulmonary, neurological and vascular risk factors that speak against the use of the intervention or participation in the study - Serious mental illness that does not allow participation in the study (e.g. severe depression, borderline) - Injury occurred more than 8 weeks ago at the time of study inclusion - Other injuries or diseases of the musculoskeletal system for which training with Novio Knee is not possible from the doctor's point of view - Re-rupture of the cruciate ligament - Osteoarthritis in the affected knee joint (Kellgren > II) - Multiligament injuries with more than 3 ligament lesions - Bony tears of the anterior cruciate ligament - Accompanying cartilage damage as soon as this is treated surgically - Dislocation of the knee - Intra-articular or periarticular fractures - Oncological diseases such as malignant tumors or metastases - Bone metabolism disorders such as known osteoporosis - Coagulation disorders, e.g. increased tendency to bleed - Severe or acute cardiovascular diseases Severe or acute metabolic diseases, e.g. uncontrolled diabetes mellitus - Autoimmune diseases that speak against participation in the study, e.g. rheumatoid polyarthritis - Other (acute) injuries or illnesses which, in the opinion of the study physician, would influence the treatment regimen planned for the study (e.g. pre- and post-operative phases in surgical cases) or could distort the study results and/or for which training with Novio Knee is not possible Contraindications of the medical device: - H54.0 Blindness and severe visual impairment, binocular - I26 Pulmonary embolism - I50 Heart failure - J18 Pneumonia - I80.2 Thrombosis, phlebitis and thrombophlebitis, other deep vessels of the lower extremities - M22.0 Habitual dislocation of the patella - M23.4 Free joint body in knee joint - M24.07 Free joint body: ankle and foot (tarsus, metatarsus, toes, ankle, other joints of foot) - M00 Purulent arthritis - M01 Direct joint infections in infectious and parasitic diseases classified elsewhere
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| KOOS = Knee Injury and Osteoarthritis Outcome Score - KOOS-Pain - KOOS-Activity of daily living - KOOS-Symptoms - Numeric Pain Rating Scale - NPRS Measurement time points of operational cohort: - T0 (baseline survey) - T1 (3-5 days pre-op) - T2 (3-5 days post-operative) - T3 (interim survey 2 weeks post-op) - T4 (interim survey 6 weeks post-op) - T5 (final survey after 12 weeks post-op) Measurement time points conservative cohort: - T0 (baseline survey) - T1 (interim survey 2 weeks after baseline) - T2 (interim survey 6 weeks after baseline) - T3 (interim survey 12 weeks after baseline) | — |
Secondary
| Measure | Time frame |
|---|---|
| - KOOS-Quality of Life - KOOS Sports - Safety (AE, SAE, etc.) Measurement time points: see above | — |
Countries
Germany
Contacts
Gelenkzentrum Mittelrhein